Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms Yttrium Y 90 anti-CD45 monoclonal antibody AHN-12(Masonic Cancer Center, University of Minnesota), 90Y AHN12, 90Y-AHN12 |
Target |
Action inhibitors |
Mechanism CD45 inhibitors(Leukocyte common antigen inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | United States | 01 Dec 2013 | |
Acute Myeloid Leukemia | Phase 1 | United States | 01 Dec 2013 | |
Myelodysplastic Syndromes | Phase 1 | United States | 01 Dec 2013 | |
Philadelphia chromosome positive chronic myelogenous leukemia | Phase 1 | United States | 01 Dec 2013 |